This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Astrazeneca Ab, Mitsubishi Tanabe Pharma Corporation. Active years: 2023.
Company Filing History:
1 out of 1,531 
1 out of 263 
Years Active: 2023
Title: Ryuichi Fuchigami: Innovator in Pharmaceutical Compounds
Introduction
Ryuichi Fuchigami is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Fuchigami holds a patent for "Compounds and their use." This patent relates to compounds of Formula (I) and their pharmaceutically acceptable salts. These compounds are identified as modulators of RXFP1 and may be beneficial in treating or preventing various diseases and conditions, including heart failure, chronic kidney disease, and acute kidney injury. The patent also covers compositions that include these compounds, as well as the processes for preparing them.
Career Highlights
Throughout his career, Ryuichi Fuchigami has worked with prominent companies in the pharmaceutical industry, including AstraZeneca and Mitsubishi Tanabe Pharma Corporation. His work has focused on innovative solutions to complex health issues, showcasing his commitment to advancing medical science.
Collaborations
Fuchigami has collaborated with esteemed colleagues such as Kenneth Lars Granberg and Shigeki Sakamaki. These partnerships have contributed to the development of groundbreaking pharmaceutical innovations.
Conclusion
Ryuichi Fuchigami's contributions to the field of pharmaceuticals through his innovative compounds and collaborations highlight his role as a key inventor in the industry. His work continues to impact the treatment of critical health conditions.